Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Unknown 2

Sponsor Class

OTHER 2

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

Gastrointestinal 2

Conditions

Neoplasms 2Endometrial Neoplasms 2Carcinoma, Non-Small-Cell Lung 2Carcinoma, Hepatocellular 2Adenocarcinoma of Lung 2Uterine Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Solid Tumor 1Radiomics 1Prostatic Neoplasms 1Pituitary Diseases 1Pancreatic Neoplasms 1Pancreatic Ductal Adenocarcinoma 1Neuroendocrine Tumors 1Lung Neoplasms 1Lung Diseases 1Liver Cirrhosis 1Hepatitis B 1Head and Neck Neoplasms 1Disease Progression 1Carcinoma, Squamous Cell 1Carcinoma, Renal Cell 1Carcinoma, Lobular 1Carcinoma, Ductal, Breast 1Breast Neoplasms 1Bone Neoplasms 1

Interventions

Sorafenib 131lenvatinib 115Bevacizumab 88Radiosurgery 69atezolizumab 55sintilimab 54Nivolumab 51durvalumab 43Hepatectomy 43Fluorouracil 42apatinib 41Oxaliplatin 41camrelizumab 38Radiofrequency Ablation 38pembrolizumab 36Radiotherapy 36tislelizumab 35Leucovorin 31Magnetic Resonance Spectroscopy 30Immune Checkpoint Inhibitors 28Doxorubicin 28Folfox protocol 26tremelimumab 25regorafenib 25Cisplatin 20spartalizumab 19donafenib 19Gemcitabine 19Cyclophosphamide 19toripalimab 18

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
OTHER × Carcinoma, Hepatocellular × Radiomics × Clear all
NCT03917017 2022-02-15

The Evaluation of Surgical Decisions and Prognosis of the Radiomics and Watson Artificial Intelligence in Patients With Hepatocellular Carcinoma

Zhujiang Hospital

Phase NA Unknown
100 enrolled
Gastrointestinal

Carcinoma, Hepatocellular

NCT03221049 2021-09-02

Radiomics for Diagnosing Liver Diseases and Evaluating Progression

Third Affiliated Hospital, Sun Yat-Sen University

Unknown
3,000 enrolled
Gastrointestinal

Hepatitis B, Carcinoma, Hepatocellular, Liver Cirrhosis, Disease Progression

Data powered by HemOnc (CC BY 4.0) Colophon âš¡